Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Monitoring Disease Burden and Biology using Tumor Cell Free DNA in Metastatic Kidney Cancer

Kidney (Renal Cell)

This study assesses whether DNA released by kidney cancer into the blood stream and urine of patients can be used to monitor tumor burden and tumor response to treatment in patients receiving immunotherapy. Studying samples of blood and urine from patients with kidney cancer that has spread to other places in the body (metastatic) in the laboratory may help doctors predict how well patients will respond to treatment.
Kidney (Renal Cell)
N/A
Haake, Scott
NCT04883827
VICCURO2144

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: